13F-HR filed by Vivo Capital, LLC
Vivo Capital, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-02, with 26 holding rows worth $397,070,000.
- Accession
- 0001214659-17-004735
- Filer
- CIK 1674712
- Filed
- 2017-08-02
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 26 entries on the cover page, a total value of $397,070,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $397,070,000 with VALUE read as thousands by filing date, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,858,569 | $77,524,000 | thousands by filing date | |
| Biohaven Pharmaceutical Holding Company Ltd | 0G1196105 | Common | 1,976,818 | $49,420,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,766,832 | $49,047,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 4,021,559 | $42,146,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 5,294,825 | $28,857,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 1,119,189 | $22,227,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 3,000,000 | $21,450,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 776,813 | $15,971,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 1,787,091 | $14,118,000 | thousands by filing date | |
| ADVANCED ACCELERATOR APPLIC SPONSORED ADS | 00790T100 | ADR | 358,786 | $14,007,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 704,225 | $8,208,000 | thousands by filing date | |
| Capnia, Inc. | 14066L105 | Common | 14,695,264 | $7,362,000 | thousands by filing date | |
| BIOPHARMX CORP | 09072X101 | COM | 14,096,338 | $6,752,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 1,013,149 | $6,211,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 1,513,975 | $5,677,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 1,728,000 | $3,974,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 855,000 | $3,967,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 359,827 | $3,472,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 164,403 | $3,247,000 | thousands by filing date | |
| Sierra Oncology, Inc. | 74346L101 | common | 2,438,270 | $2,853,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 527,842 | $2,433,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 148,878 | $2,385,000 | thousands by filing date | |
| KalVista Pharmaceuticals, Inc. | 048349710 | Common | 300,325 | $2,210,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 77,373 | $2,043,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 500,000 | $1,350,000 | thousands by filing date | |
| CAPNIA INC | 14066L113 | *W EXP 11/12/201 | 943,858 | $159,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-17-004735 | this filing | 2017-08-02 | acceptance time not in the bulk data set |